News

Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets


 

More than 64,000 bottles of 10-mg generic atorvastatin tablets have been recalled, according to a notice on the Food and Drug Administration website.

The nationwide recall applies to 64,626 bottles that contain 90 tablets, and are manufactured by Ranbaxy Pharmaceuticals. The discovery of a 20-mg atorvastatin tablet in a sealed 90-count bottle of atorvastatin 10-mg tablets was the basis of the recall.

The recall is voluntary and was initiated by Ranbaxy in January 2014.

The affected bottles are pharmacy dispensing bottles, a Ranbaxy spokesperson said.

Lipitor is the brand-name version of atorvastatin.

emechcatie@frontlinemedcom.com

Recommended Reading

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes
MDedge Internal Medicine
Too much dietary sugar raises CVD mortality
MDedge Internal Medicine
New stroke guidelines focus on women’s risks
MDedge Internal Medicine
Endocrine Society calls for trials on testosterone’s cardiovascular effects
MDedge Internal Medicine
FDA to probe saxagliptin’s heart failure risk
MDedge Internal Medicine
Obesity at age 20 associated with increased risk of multiple sclerosis
MDedge Internal Medicine
NIH and pharma partner on RA, lupus, diabetes, Alzheimer’s research
MDedge Internal Medicine
Thyroid cancer rise mostly overdiagnosis
MDedge Internal Medicine
The future of obesity treatments could include endoscopically placed devices
MDedge Internal Medicine
Curb vaccine-preventable diseases in diabetes patients
MDedge Internal Medicine